Ayse Bozkurt

Ayse Bozkurt

Auto-generated profile, based on publicly available information

Ayse Bozkurt

Van Yuzuncu Yil University, Faculty of Pharmacy, Department of Pharmacology, 65100 Van, Turkey; Ataturk University, Faculty of Medicine, Department of Medical Pharmacology, 25240 Erzurum, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
ABAyse Bozkurt
Ayse Bozkurt
HHHamza Halici
Hamza Halici
MYMuhammed Yayla
Muhammed Yayla
Inflammation involves a long chain of molecular reactions and cellular activity designed to repair tissue damaged by various causes. The inflammatory process and its complex mechanisms have recently become a focus of interest for many researchers. After the onset of inflammation, various adverse conditions that initiate the inflammatory response need to be addressed; however, failure to limit the inflammatory reaction may result in the damage or destruction of host cells. Therefore, inflammatory reactions play a role in many diferent diseases. Aquaporins (AQPs), commonly referred to as water channels, are protein channels responsible for forming pores in the membranes of biological cells. Their main function is to aid in the movement of water between cells. Aquaporins not only regulate transepithelial fluid transport across membranes but also play a role in regulating essential events crucial for the inflammatory response. Aquaporins have been shown in many studies to have important roles in inflammatory diseases. This clearly indicates that AQPs may be potential targets for inflammatory diseases. This review summarizes the research to date on the structure and function of AQPs and provides an update on the relationship between AQPs and various human inflammatory diseases Cite this article as: Bozkurt A, Halici H, Yayla M. Aquaporins: potential targets in inflammatory diseases. Eurasian J Med., 2023;55(Suppl. Issue: 1): S106-S113.

7 March 2024 in Reproductive Sciences
Verified
Journal Article
Open access
PDF file
ABAyse Bozkurt
Ayse Bozkurt
ZKZeynep Karakoy
Zeynep Karakoy
PAPelin Aydin
Pelin Aydin
BOBengul Ozdemir
Bengul Ozdemir
ETErdem TOKTAY
Erdem TOKTAY
ECELIF CADIRCI
ELIF CADIRCI
This study aimed to examine the effect of Phosphodiesterase 4 (PDE4) inhibition on Aquaporin-5 (AQP5) and its potential cell signaling pathway in the ovarian ischemia reperfusion (OIR) model. Thirty adult female rats were divided into five groups: Group 1; Control: Sham operation, Group 2; OIR that 3 hour ischemia followed by 3 hour reperfusion, Group 3; OIR + Rolipram 1 mg/kg, Group 4; OIR + Rolipram 3 mg/kg, Group 5; OIR + Rolipram 5 mg/kg. Rolipram was administered intraperitoneally to the rats in groups 3-4 and 5 at determined doses 30 minutes before reperfusion. From ovary tissue; Tumor necrosis factor-a (TNF-α), Cyclic adenosine monophosphate (cAMP), Nuclear factor kappa (NF-κB), Interleukin-6 (IL-6), Phosphodiesterase 4D (PDE4D), Mitogen-activated protein kinase (MAPK) and AQP5 levels were measured by ELISA. We also measured the level of AQP5 in ovary tissue by real-time reverse-transcription polymerase chain reaction (RT-PCR). In the OIR groups; TNF-α, NF-κB, IL-6, MAPK inflammatory levels increased, and cAMP and AQP5 levels decreased, which improved with the administration of rolipram doses. Also histopathological results showed damaged ovarian tissue after OIR, while rolipram administration decrased tissue damage in a dose dependent manner. We propose that the protective effect of PDE4 inhibition in OIR may be regulated by AQP5 and its potential cell signaling pathway and may be a new target in OIR therapy. However, clinical studies are needed to appraise these data in humans.

15 September 2023 in Namık Kemal Tıp Dergisi
Verified
Journal Article
Open access
TYTuğba Nurcan YUKSEL
Tuğba Nurcan YUKSEL
ZHzekai halici
zekai halici
CKCihangir Kaya
Cihangir Kaya
ABAyşe BOZKURT
Ayşe BOZKURT
TTTaha Tavaci
Taha Tavaci
BÖBengül Özdemi̇r
Bengül Özdemi̇r

8 December 2025 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
ABAyse Bozkurt
Ayse Bozkurt
ZBZafer Bayraktutan
Zafer Bayraktutan
ETErdem TOKTAY
Erdem TOKTAY
AKAdem Kara
Adem Kara
ZHzekai halici
zekai halici
ECELIF CADIRCI
ELIF CADIRCI
This study aimed to examine the relationship between Phosphodiesterase 4 (PDE4) and Aquaporin-5 (AQP5) under Lipopolysaccharide (LPS) induced-inflammatory condition. Inflammatory Acute lung injury (ALI) was induced by intratracheal LPS (5 mg/kg) administration. Rolipram (intraperitoneal) was used as PDE4 inhibiting agent at three different doses (1, 3 and 5 mg/kg) in rat groups. 24 h after LPS administration lung tissues obtained and following analyses performed. AQP5, Phosphodiesterase 4D (PDE4D), Cyclic adenosine monophosphate (cAMP) levels were evaluated for determination of the relationship between these parameters. Also Interleukin-6 (IL-6), Tumor necrosis factor-α (TNF-α), Nuclear factor kappa B (NF-κB), Mitogen-activated protein kinase (MAPK) levels were evaluated as ALI markers. LPS-induced ALI resulted in increased PDE4 enzyme and inflammatory marker levels (IL-6, TNF-α, NF-κB and MAPK) and decreased AQP5 and cAMP levels. Inhibition of PDE4 enzyme to increase cAMP levels by Rolipram resulted in increased AQP5 expression and decreased inflammatory condition and in lung tissues. These results were supported by histopathological and immunhistochemical results. The fact that this study observed a decreases PDE4 expression and increases in AQP5 expression upon Rolipram administration might indicate a close relationship of these two parameters in inflammatory lung disease.

13 October 2026
Verified
Book
Closed access
ACAlperen Canpolat
Alperen Canpolat
ABAyşe Bozkurt
Ayşe Bozkurt
AÖAyşegül Tavacı Özçelik
Ayşegül Tavacı Özçelik
BUBetül Sena Uyanık
Betül Sena Uyanık
CÖCihad Özçelik
Cihad Özçelik
ZKZeynep Karaköy Kaya
Zeynep Karaköy Kaya
Türkiyenin E-kitap portalı Libraryturk.com aracılığıyla Güncel Farmakoterapi ve Biyokimya Current Pharmacotherapy and Biochemistry adlı kitaba erişeblirsiniz.

8 December 2023 in Namık Kemal Tıp Dergisi
Verified
Journal Article
Closed access
KEKadir Giray Erkayman
Kadir Giray Erkayman
RURüstem Anıl UĞAN
Rüstem Anıl UĞAN
ZMZeynep Berna Aksakalli Mağden
Zeynep Berna Aksakalli Mağden
EYEda Yilmaz
Eda Yilmaz
ABAyşe BOZKURT
Ayşe BOZKURT
ECELIF CADIRCI
ELIF CADIRCI